| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 10/03/2006 | US7115623 1,8-Naphthyridin-2(1H)-one derivatives; antiasthmatic, antihistamine, and bronchodilator agents; nontoxic, side effect reduction |
| 10/03/2006 | US7115615 Antitumour agents as enzyme inhibitors of the nonreceptor tyrosine protein kinases involved in the signal transduction; noninvasive; antimetatic and -carcinogenic agents; derivatives of 4-(1,3-benzo-dioxol-4-yl)amino-)quinazoline |
| 10/03/2006 | US7115613 Compound of fused nitrogen containing heterocyclic ring, useful for treating prostate and angiogenic disorders |
| 10/03/2006 | US7115597 Tyrosine kinase inhibitors |
| 10/03/2006 | US7115594 Administering to a patient with metabolic bone disease an effective amount of 2-methylene-19-nor-20(S)-1 alpha ,25-dihydroxyvitamin D3 compound to treat osteoporosis |
| 10/03/2006 | US7115392 Polynucleotides encoding human vascular endothelial growth factor 2 |
| 10/03/2006 | US7115252 For restoration and maintenance of gingival and periodontal health; antiplaque/antitar agents; mouthwash |
| 10/03/2006 | CA2346438C Utilisation of dialkylfumarates for treating host-versus-graft reactions and auto-immune diseases |
| 10/03/2006 | CA2251840C Composition, barrier film, and method for preventing contact dermatitis |
| 10/03/2006 | CA2249348C Preparation containing a combination of 5-methylisoxazole-4-carboxylic acid-(4-trifluoromethyl)-anilide and n-(4-trifluoromethylphenyl)2-cyano-3-hydroxycrotonic acid amide |
| 10/03/2006 | CA2212440C Pharmaceutical preparations for tnf inhibition |
| 09/28/2006 | WO2006102681A2 Method of treating skin ulcers using oxidative reductive potential water solution |
| 09/28/2006 | WO2006102680A2 Method of treating second and third degree burns using oxidative reductive potential water solution |
| 09/28/2006 | WO2006101187A1 Peptides that increase collagen or hyaluronic acid production |
| 09/28/2006 | WO2006101173A1 Preparation comprising microparticles of complex composed of nucleic acid molecule and collagen |
| 09/28/2006 | WO2006101119A1 Collagen synthesis promoter |
| 09/28/2006 | WO2006101105A1 Agent for treatment of psoriasis |
| 09/28/2006 | WO2006100922A1 Cinnamoyl compound and use thereof |
| 09/28/2006 | WO2006100797A1 Method and pharmaceutical composition for treating psoriasis, squamous cell carcinoma and/or parakeratosis by inhibiting expression of squamous cell carcinoma-related antigen |
| 09/28/2006 | WO2006099930A1 Extraction method for producing plant extracts, especially waltheria paniculata extracts containing tiliroside |
| 09/28/2006 | WO2006099687A1 Sunscreen aerosol spray |
| 09/28/2006 | WO2006068485A3 Temporally meal menu for infants |
| 09/28/2006 | WO2006028810A3 Method of wound healing using a2b adenosine receptor antagonists |
| 09/28/2006 | US20060217557 Polymorphic form XVI of fexofenadine hydrochloride |
| 09/28/2006 | US20060217530 Active against C5a receptors on polymorphonuclear leukocytes and macrophages; peptidomimetics; for treatment of inflammation |
| 09/28/2006 | US20060217407 Compositions and Formulations of 9-Nitrocamptothecin Polymorphs and Methods of Use Therefor |
| 09/28/2006 | US20060217388 Phthalazine derivatives for treating inflammatory diseases |
| 09/28/2006 | US20060217378 E.g., 7-acetyl-5-tert-butylamino-6-phenyl-imidazo[2,1-b]-thiazol-7-ium chloride; treatment of pain, diarrhea, urinary incontinence, depression, and anxiety |
| 09/28/2006 | US20060217373 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same |
| 09/28/2006 | US20060217364 Beta-lactamyl vasopressin V1a antagonists |
| 09/28/2006 | US20060217363 Methods and therapeutic combinations for the treatment of hypercholesterolemia and xanthoma using sterol absorption inhibitors |
| 09/28/2006 | US20060217353 24-sulfoximine vitamin D3 compounds |
| 09/28/2006 | US20060217349 Having antiinflammatory, anti-pyretic and anti-diarrheal properties |
| 09/28/2006 | US20060216745 Polynucleotides, expression vectors, and host cells for culturing truncated tryptophanyl-tRNA synthetase polypeptides having chemokine activity; bioassay; drug screening; antitumor agents, antimetastasis agents |
| 09/28/2006 | US20060216301 Kdr peptides and vaccines containing the same |
| 09/28/2006 | US20060216289 GFRalpha3 and its uses |
| 09/28/2006 | US20060216261 Nanoemulsion comprising metabolites of ginseng saponin as an active component and a method for preparing the same, and a skin-care composition for anti-aging containing the same |
| 09/28/2006 | US20060216249 Use of a cosmetic of pharmaceutical composition, comprising a lupeol-rich extract as an active ingredient for stimulating the synthesis of heat shock proteins |
| 09/28/2006 | CA2602522A1 Method of treating skin ulcers using oxidative reductive potential water solution |
| 09/28/2006 | CA2602411A1 Method of treating second and third degree burns using oxidative reductive potential water solution |
| 09/28/2006 | CA2601373A1 Fine particulate preparation comprising complex of nucleic acid molecule and collagen |
| 09/28/2006 | CA2599794A1 Cinnamoyl compound and use thereof |
| 09/27/2006 | EP1704139A1 DISUBSTITUTED CHALCONE OXIMES AS SELECTIVE AGONISTS OF RAR y RETINOID RECEPTORS |
| 09/27/2006 | EP1703795A2 Beta vulgaris-based products |
| 09/27/2006 | EP1534687B1 2-phenylamino-4-trifluoromethyl-5-(benzyl- or pyridin-4-ylmethyl)carbamoylpyrimidine derivatives as selective cb2 cannabinoid receptor modulators |
| 09/27/2006 | EP1511496B1 Method of treating or preventing immune mediated disorders and pharmaceutical formulation for use therein |
| 09/27/2006 | EP1450792B1 Benzazole derivatives for the treatment of scleroderma |
| 09/27/2006 | EP1337521B1 Salts of an isothiazole-4-carboxamide and their use as anti-hyperproliferation agents |
| 09/27/2006 | EP1303537B1 Ho-1 suppressor as a diagnostic and prognostic test for dementing diseases |
| 09/27/2006 | EP1196433B1 CYCLIC PEPTIDE DERIVATIVES AS INHIBITORS OF INTEGRIN ALPHA v BETA 6 |
| 09/27/2006 | CN1838952A Use of [3.2.0] heterocyclic compounds and analogs thereof for the treatment of cancer, inflammation and infectious diseases |
| 09/27/2006 | CN1836728A Use of neutral proteinase in treating burn |
| 09/27/2006 | CN1836717A Quality controlling method for pulse restoring injection |
| 09/27/2006 | CN1836701A Scald-treating medicine |
| 09/27/2006 | CN1836699A Multifunctional health liquid |
| 09/27/2006 | CN1836669A Method for preparing sheep placenta extract |
| 09/27/2006 | CN1276776C Ointment for antipruritic and removing dandruff |
| 09/27/2006 | CN1276763C Chinese traditional medicine composition for treating bedsore and acute soft tissue injury |
| 09/26/2006 | US7112654 Ligand for vascular endothelial growth factor receptor |
| 09/26/2006 | US7112611 Antitumor, anticancer agents; respiratory system disorders; brain disorders |
| 09/26/2006 | US7112603 Prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives |
| 09/26/2006 | US7112597 5-(Substituted thiazolylethoxy)indaneacetic acid derivatives, used in the treatment of diseases such as diabetes, obesity, hyperlipidemia, and atherosclerotic diseases |
| 09/26/2006 | US7112592 Azabicyclic compounds, preparation thereof and use as medicines, in particular as antibacterial agents |
| 09/26/2006 | US7112580 3-nitrogen-6, 7-dioxygen steroids and uses related thereto |
| 09/26/2006 | US7112579 26,27-Homologated-20-EPI-2-alkyl-19-nor-vitamin D compounds |
| 09/26/2006 | US7112574 found to be potent adenosine receptor agonists, in particular for the A2A receptor. |
| 09/26/2006 | US7112568 an anti-allergic agent, comprising a molecule having at least a first segment competent for importation of the molecule into mast cells, and a second segment for having an anti-allergic effect within the mast cells |
| 09/26/2006 | US7112415 Method of preparing cell cultures from biological specimens for assaying a response to an agent |
| 09/21/2006 | WO2006098625A1 Dermatologic use of milk proteins |
| 09/21/2006 | WO2006098519A1 Pyrazolopyrimidine derivative or pharmaceutically acceptable salt thereof |
| 09/21/2006 | WO2006098422A1 Anti-alopecia agent using super anti-apoptotic protein fnk |
| 09/21/2006 | WO2006098353A1 External preparation |
| 09/21/2006 | WO2006097707A2 Skin composition treatment |
| 09/21/2006 | WO2006097628A1 Composition based on an avermectin and azelaic acid in particular for treating rosacea |
| 09/21/2006 | WO2006097337A2 11β-HYDROXYSTEROID DEHYDROGENASES |
| 09/21/2006 | WO2006096914A1 A topical analgesic composition |
| 09/21/2006 | WO2004089282A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 09/21/2006 | US20060212025 Method and apparatus for acne treatment |
| 09/21/2006 | US20060211764 Cell activator, process for producing cell activator and apparatus therefor |
| 09/21/2006 | US20060211696 IMIDAZO[1,2-b]PYRIDAZINE COMPOUND |
| 09/21/2006 | US20060211694 antiinflammatory agent for treating asthma and chronic pulmonary inflammatory disease |
| 09/21/2006 | US20060211680 decreases expression of a Type I collage gene in a tissue to induce a reduction in accumulation of collagen and thereby improves tissue fibrosis |
| 09/21/2006 | US20060211661 24 hydroxyvitamin d, analogs and uses thereof |
| 09/21/2006 | US20060211659 Novel compounds of the N-acylamino amide family, compositions comprising them and uses thereof |
| 09/21/2006 | US20060211618 Polynucleotides and polypeptides of the erythropoietin gene |
| 09/21/2006 | US20060211602 Use of alanyl aminopeptidase inhibitors and pharmaceutical compositions containing said inhibitors |
| 09/21/2006 | US20060210619 Limposomes containing asiaticoside and the uses thereof |
| 09/21/2006 | US20060210593 Methods of making and methods of using antiseptic disinfectant, cosmetic and toiletries, medicine or food containing the same |
| 09/21/2006 | US20060210553 Topical use of tyrosine kinase inhibitors of microbial origin to prevent and treat skin disorders characterised by excesssive cell proliferation |
| 09/21/2006 | US20060210550 Angiogenesis inducer |
| 09/21/2006 | DE4404086B4 Pharmazeutische und/oder kosmetische Zusammensetzung Pharmaceutical and / or cosmetic composition |
| 09/21/2006 | DE4404085B4 Pharmazeutische und/oder kosmetische Zusammensetzung Pharmaceutical and / or cosmetic composition |
| 09/21/2006 | DE202006010673U1 Natural cure, useful for treating heavy healing wounds, comprises active substance component from marigold (Calendula officinalis), arnica (Arnica montana), comfrey (Symphytum officinalis) and camomile (Matricaria chamomilla) in broth |
| 09/21/2006 | DE102005012060A1 Orales Produkt zur Vorbeugung und Behandlung von Windeldermatitis Oral product for the prevention and treatment of diaper rash |
| 09/21/2006 | DE102005011785A1 Langzeitstabile kosmetische Emulsionen Long-term stable cosmetic emulsions |
| 09/21/2006 | DE102005011498A1 Verwendung kosmetischer Zubereitungen mit einem Gehalt an nicht molekular gebundenem freien Sauerstoff Use of cosmetic preparations containing not molecularly bonded free oxygen |
| 09/21/2006 | DE102005011457A1 Verwendung kosmetischer Zubereitungen mit einem Gehalt an nicht molekular gebundenem freien Sauerstoff Use of cosmetic preparations containing not molecularly bonded free oxygen |
| 09/21/2006 | CA2656966A1 A topical analgesic composition |
| 09/21/2006 | CA2601717A1 Pyrazolopyrimidine derivative or pharmaceutically acceptable salt thereof |
| 09/21/2006 | CA2601123A1 External preparation |